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Objectives: to investigate the results of revision of recurrent stenoses after superficial femoral artery (SFA) remote
endarterectomy.
Design: prospective, non-open, study.
Materials: eighty-eight consecutive patients with long segmental SFA occlusive disease underwent 101 remote end-
arterectomy procedures. All patients had chronic lower extremity ischaemia necessitating surgical intervention.
Methods: clinical, haemodynamic, and duplex examinations were performed postoperatively at regular intervals, identifying
46 recurrent stenosed (PSV ratio >2.5) limbs, which formed the cohort for this study. The median follow-up was 25
months. Secondary revision was performed in 23 limbs, based on recurrent symptoms and individual preference of the
attending vascular surgeon. Cumulative primary and primary assisted-patency rates were compared using the log-rank
test of significance.
Results: univariate analysis did not show any significant differences for other demographic and lesion characteristics
apart from recurrent symptoms (all revised). Multivariate analysis revealed that revision “adjusted for time-of-onset”
predicted reocclusion (p=0.007; HR 0.21; 95% CI 0.06, 0.66). Among subjects in whom restenoses developed within 1
year, revision of recurrent stenoses improved primary patency rates from 47% to 77% at 30 months.
Conclusions: revision of early (<1 year) recurrent stenoses improves the mid-term patency rates of SFA remote
endarterectomy.
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Introduction some of these recurrent stenoses are without clinical
or haemodynamic worsening.8–13 At present, colour-
flow duplex is used routinely in many postoperativeSemi-closed superficial femoral artery (SFA) end-
graft surveillance programmes for detection and sub-arterectomy provides a valuable alternative to the
sequently revision of recurrent stenoses before throm-current treatment options for SFA occlusive disease
bosis occurs.14–17 We are now aware of the incidencewith reported long-term patency rates of up to 71%.1–3
and fate of (a)symptomatic graft stenoses after bypassAlthough the natural history of infrainguinal grafts
surgery.18–23 Timely revision of these graft stenoseshas already been described, the fate of (non-)revised
has become an accepted strategy that prolongs graftrestenosed limbs after SFA endarterectomy is still un-
patency.18,19,24,25 Analogously, failure after end-known.
arterectomy may be preceded by similar recurrent SFAAs recurrent progressive stenoses appears to be
stenoses. We have recently reported a 46% incidencethe most important determinant of infrainguinal graft
of recurrent stenoses after SFA remote end-failure, identification of these graft stenoses is crucial.4
arterectomy.26 In some selected cases, revision of re-Early traditional methods of surveillance relied on
current stenoses was performed. However, no reportsrecurrence of symptoms, change in the character of
are available yet concerning the results of revision ofpedal pulses, or a decrease in the ankle–arm pressure
restenoses after endarterectomy. If revision of re-index (ABPI).5–8 These techniques have been shown to
current stenoses indeed enhances long-term patencybe insufficient to detect impending graft failure, as
rates, perhaps this would further help to define the
role of SFA endarterectomy.
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duplex scanning after superficial femoral artery (SFA) an intraoperative angiography to ensure technical ad-
equacy. Patients were given oral anticoagulants oneremote endarterectomy procedures could improve the
mid-term patency rates. day prior to surgery, and this was continued for a
minimum of 6 months.
Patients were investigated with colour-flow duplex
scanning (HP Sonos 2000, Hewlett Packard Company,
Materials and Methods Imaging Systems Division, Andover, MA, U.S.A.)
within 1 to 6 weeks and 3 months following SFA remote
Patient population endarterectomy, and then at 3-monthly intervals for
the first year, and annually thereafter. Stenotic seg-
From March 1994 up to the end of June 1996, 101 SFA ments were identified by local increased peak systolic
remote endarterectomy procedures were performed velocity (PSV) at the site of stenosis (PSV-max) com-
in 88 consecutive patients with long segmental SFA pared with the peak systolic velocity of a nearby
occlusive disease. This study was approved by our normal arterial segment (PSV-normal). A PSV-ratio
Institutional Review Board and informed consent was (PSV-max/PSV-normal) >2.5 was considered a 50%
obtained from all patients. Demographic data and risk diameter reduction (DR) or more, as classified ac-
factors for atherosclerosis were collected from the cording to previously validated criteria from our in-
patient’s medical records. Preoperative assessment stitution by Legemate et al.28 Multiple stenoses were
included measurement of Doppler ankle–brachial defined as more than one restenosis within the treated
blood pressure index (ABPI), treadmill tests and arteri- femoropopliteal segment. If multiple lesions were de-
ography for the evaluation of the femoropopliteal tected, only the most severe lesion in any limb was
lesions (stenosis/occlusions less or more than half of considered for analysis in this study. Clinical and
the SFA) and scoring of the run-off vessels. Aortoiliac haemodynamic sustained improvements were evalu-
inflow vessels were evaluated either by angiography or ated by recurrent symptoms and ankle–brachial blood
duplex scanning. All 101 SFA remote endarterectomy pressure index (ABPI) measurements by standard
procedures entered our duplex surveillance pro- Doppler techniques at every follow-up visit before
gramme. Until November 1997, a total of 488 colour- and after treatment of any recurrent lesion.
flow duplex scans were done as part of this. One Revision of recurrent stenosis was based on the
patient with a reocclusion at first duplex follow-up presence of recurrent symptoms and the individual
after 6 weeks was excluded from this study. In 46 preference of the attending vascular surgeon. The
(46%) limbs of 42 patients, serial colour-flow duplex primary end-point was any reocclusion. Secondary
examination detected significant recurrent stenoses end-points were limb salvage, or death after con-
within the endarterectomised SFA or at the proximal servative treatment or revision of any (a)symptomatic
or distal end after a mean follow-up of 25 months. recurrent stenosis. A reduction in ABPI between pre-
These 42 patients formed the cohort of this study. and postoperative values of more than 0.15 was re-
At our institution, remote endarterectomy is the garded as a significant pressure reduction and an
treatment of choice in those patients with supra- indicator for disease progression. Outcomes were ana-
genicular femoropopliteal occlusive disease, not amen- lysed according to treatment selected, demographic
able for percutaneous transluminal angioplasty. Veins, data, maximum PSV-ratio, location, and time-of-onset
if available, are spared for infragenicular femorodistal of the restenoses. Univariate analysis was performed
reconstructions. Remote endarterectomy is a modified to assess any differences between the revised and non-
semi-closed endarterectomy procedure described revised treatment group. The Kaplan–Meier method
earlier, using an arterial loop stripper (Aesculap-Werke was used to calculate the cumulative patency rate of the
AG, Tu¨ttlingen, Germany) and a ring-strip cutter de- remote endarterectomies and for graphic comparison.
vice (Mollring CutterÔ, Aspect Medical Inc., Portola The log-rank test was used to assess the significance
Valley, CA, U.S.A.) to perform an endarterectomy of of differences in patency rates between the revised and
the entire SFA through a single groin incision.27 A the non-revised group. The Cox Proportional Hazard
balloon-expandable Palmaz stent (P154, P204, or P294; Model was used to adjust for confounders.
Johnson and Johnson Interventional Systems, Warren,
NJ, U.S.A.) is deployed to tack down the distal intimal
edge. All procedures were performed at the vascular Results
surgical suite by a vascular surgeon in close col-
laboration with an interventional radiologist. Each The mean age of the 27 males and 15 females was 65
(range 43–78) years. The incidence of risk factors forremote endarterectomy procedure was completed with
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Table 1. Baseline lesion characteristics before SFA remote endarterectomy in non-revised and revised 46 restenosed limbs.
Treatment group
Variable Non-revised Revised p value
n=23 n=23
SFA occlusion (n) 21 22 n.s.
Length remote endarterectomy (mean (95% CI)) (cm) 30.7 (28.5–33.0) 32.6 (30.3–34.8) n.s.
Presenting symptoms
Category 1–3 (n) 17 15 n.s.
Category 4–5 (n) 6 8 n.s.
Crural run-off score (mean: (95% CI)) 2.5 (1.6–3.3) 3.8 (2.8–4.7) 0.054
n.s.=not significant.
Table 2. Characteristics of 46 recurrent stenoses after SFA remote endarterectomy in non-revised and revised groups.
Treatment group
Non-revised Revised p value
n=23 n=23
Max. PSV ratio (mean: (95% CI)) 4.4 (3.8–5.1) 5.0 (4.2–5.8) n.s.
ABPI at time of max. restenosis (mean: (95% CI)) 0.98 (0.91–1.05) 0.94 (0.88–1.00) n.s.
Recurrent symptoms (n) 0 10 0.001
Multiple lesions (n) 9 12 n.s.
Site of lesion
Proximal SFA (n) 11 5 n.s.
Mid/dist SFA (n) 7 11
Stent/popliteal (n) 5 7
Time-of-onset restenoses (median; interquartile range) (months) 6.1 (4.7–14.5) 6.0 (5.0–8.6) n.s.
Restenosis <1 year (n) 17 21 n.s.
Restenosis >1 year (n) 6 2
n.s.=not significant.
atherosclerosis was: smoking 26/42 (62%); diabetes were found in the PR group (p<0.001). There were no
other significant differences observed between the PR10/42 (24%); hypercholesterolaemia 13/42 (32%) and
hypertension 31/42 (74%). Associated symptomatic and PNR group with respect to risk factors, demo-
graphic variables, or lesion characteristics. Further-coronary disease was present in 13 (32%) patients and
cerebrovascular disease in five (12%). All patients were more, the run-off score in the PR group tended to be
higher than in the PNR group, indicating that the run-treated for chronic lower-extremity ischaemia Ca-
tegory 1–3 in 32/46 (70%), Category 4 in 5/46 (11%), off was worse in the PR group (p=0.054).
and Category 5 in 9/46 (19%) limbs, according to the
Rutherford classification (SVS/ISCVS-NA criteria).29
All patients in Category 1–3 had disabling claudication
for at least 6 months that had not responded to con- Revision group (PR)
servative management. Femoropopliteal lesions con-
sisted of long occlusions 43/46 (93%) or multiple All 10 symptomatic recurrent stenoses underwent re-
vision. At the discretion of the attending physician,stenoses 3/46 (7%). In 18/43 (42%) cases, the SFA was
occluded throughout most of its length, whereas the 13 other asymptomatic limbs with recurrent stenoses
were revised. The decision not to revise a stenosis wasremaining 15 cases were comprised of SFA occlusions
for less than half its length. The mean length (range) of influenced by a stable PSV ratio, a normal ABPI,
unwillingness of the patient to undergo a secondthe endarterectomised segment was 32 cm (17–45 cm).
During follow-up, 23 limbs with positive scans procedure, or reluctance of the surgeon to subject an
asymptomatic patient to operation or percutaneousunderwent revision (positive revised: PR), whereas
the remaining 23 limbs with positive scans were treated transluminal angioplasty (PTA). The median time in-
terval from operation to revision was 7.7 (interquartileconservatively (positive non-revised: PNR). Univariate
analysis showed that “recurrent symptoms” was the range 6.4–14.3) months. The mean PSV ratio im-
mediately before revision was 4.99 (95% Confidenceonly variable that differed for the two treatment groups
(Tables 1 and 2). All 10 symptomatic recurrent stenoses Interval (CI) 4.20–5.79). This was similar to the PSV
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Fig. 1. Angiography at 6 months after SFA remote endarterectomy, showing recurrent stenosis at the location of the distal SFA (stent);
(A) normal PSV values proximal to the restenosis; (B) increased PSV values at level of restenosis.
ratio in the PNR group. All patients had pre-procedural total occlusion within a few days thereafter. All
patients recovered uneventfully and no amputationsangiography prior to revision (Fig. 1). In 20 cases PTA
was performed simultaneously during this procedure, were necessary in this group. The remaining 18/23
revised limbs are still patent after a mean interval ofwhen the lesions were suitable for balloon-dilatation
(Fig. 2). Surgical revision was done in three cases. In 28.8 months.
these cases, myointimal hyperplasia was found. Two
patients had an interposition graft and stent graft
implanted, and one underwent a vein patch angio-
plasty. Non-revision group (PNR)
Five of the 23 revised stenoses (22%) (95% CI 0.05,
0.39) progressed to occlusion. Four recurrent stenoses Twenty-three stenosed limbs were treated conservat-
ively. These patients did not show any worsening ofwere revised after 4, 5, 6, and 12 months, but eventually
occluded after respectively 11, 28, 12, and 25 months symptoms, which was the main reason why these
lesions were treated conservatively. Ten restenosedafter the first operation. Two of these had recurrent
stenoses after revision. One patient needed additional limbs (43%) (95% CI 0.23, 0.64) eventually progressed
to occlusion. Six reocclusions were accompanied withtreatment after his entire femoropopliteal segment
thrombosed. He successfully underwent femorocrural worsening of symptoms. One patient underwent ven-
ous femoropopliteal bypass surgery. Conservativebypass surgery. The fifth failure occurred after a com-
plicated revision of a symptomatic stenosis at the treatment was continued in the other five patients. No
amputations were necessary in this group. Elevendistal SFA at 19 months. This patient had developed
a stenosis at the anastomosis of a short PTFE inter- limbs remained patent with a stable functional/
haemodynamic situation. Two patients died due toposition graft, which was used during the remote
endarterectomy procedure because of a perforation. A prostate cancer and myocardial infarction after 24
and 25 months with a stable stenosis. The mean timePTA procedure was performed but this resulted in a
Eur J Vasc Endovasc Surg Vol 19, January 2000
Revision of Restenosis 39
Fig. 2. Angiogram after treatment of the restenosis with a 5-mm balloon showing normal vessel lumen; (C) and (D) normalised PSV
values after revision.
interval from operation to the detection of restenoses
of the 10 reoccluded limbs was 4.7 months, whereas
the mean time-of-onset for restenoses of the remaining
PNR limbs was more than 12 months.
Division of the PNR group into two subgroups
with stenoses detected within and after the first year,
showed that all 10 reocclusions in the PNR group
occurred in the first group. Stratified for time-of-onset,
this would result in 10/17 occlusions (59%) (95% CI
0.36, 0.82) in the subgroup of restenoses within the
first year. The six restenoses in the PNR group that
developed after more than 1 year (second subgroup)
have not progressed to occlusion thus far.
Fig. 3. Cumulative primary (assisted) patency rates. Kaplan–Meier
curves represent failure by reocclusions in 23 limbs with revised
stenoses (---) and 23 limbs with non-revised stenoses (—).
Analysis of patency
Comparing the PR and PNR groups, it appears that 3). Univariate analysis showed that revision tended to
predict reocclusion (hazard ratio (HR) 0.35; 95% CIrevision of recurrent stenoses tended to improve the
primary patency rates from 60% (standard error (s.e.) 0.12, 1.06; p=0.06). Time-of-onset was another im-
portant determinant of reocclusion (HR 0.84; 95% CI0.10) to 74% (s.e. 0.10) at 30 months (p=0.054) (Fig.
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before. Therefore, revision of restenoses after SFA
remote endarterectomy seems to be justified. This is
comparable to the results of several duplex sur-
veillance studies, showing the impact of timely re-
vision of graft stenoses after conventional venous
bypass surgery.15–19 The major limitation of this study
is the fact that revision was not randomised. However,
univariate analysis showed that the revised and non-
revised groups were comparable. The only variable
that differed was “symptomatic restenoses”. Although
the median time-of-onset was similar in both treatment
groups, the mean time-of-onset in the revised group
was shorter. As the “time-of-onset” was highly pre-
dictive for reocclusion, one can argue that the revised
group was at a higher risk for reocclusion than the
non-revised group. We found that early lesions ac-
Fig. 4. Cumulative primary (assisted) patency rates. Adjusted for counted for 14 of the 15 reocclusions in this study.time-of-onset (restenosis <1 year), Kaplan–Meier curves represent
The longer “mean time-of-onset” in the non-revisedfailure by reocclusions in 21 limbs with revised stenoses (---) and
17 limbs with non-revised stenoses (—). group can be explained by the fact that this group
should be divided into two subgroups: those with
Table 3. Hazard ratio for reocclusion after SFA remote aggressive recurrent stenoses developing within the
endarterectomy with recurrent stenoses.* first year, and a small group with “benign” restenoses
RR (95% CI)** developing thereafter. This phenomenon seems iden-
tical to what has been described previously in several
Revision (yes/no) 0.35 (0.12, 1.06)
graft-surveillance studies.4,7,20–23 Apart from immediateTime-of-onset restenosis (months) 0.84 (0.71, 0.99)
Revision adjusted for time-of-onset 0.21 (0.06, 0.66) failures within the first few weeks due to technical
Subgroup restenosis <1 year; errors, one can distinguish early aggressive graft
revision (yes/no) 0.45 (0.25, 0.82)
stenoses within the first postoperative year due to
* Values obtained with Cox Proportional Hazard Model. myointimal hyperplasia from late recurrent graft
**RR=relative risk; CI=confidence interval. stenoses. These early lesions often lead to graft
failure unless corrected.18,19,21 Fifty-nine per cent of
0.71, 0.99; p=0.04). Therefore, we included time-of- the non-revised stenoses detected within the first
onset in the model as a covariate. Multi-variate analysis year progressed to occlusion. Late restenoses de-
showed that revision “adjusted for time-of-onset” was veloping after the first postoperative year due to
highly significant to predict reocclusion (p=0.007; HR progression of the underlying atherosclerosis seems
0.21; 95% CI 0.06, 0.66). Stratified for time-of-onset to have a fairly benign course.20,22 In our series, none
(within 1 year), revision of recurrent stenoses im- of the six late non-revised stenoses progressed to
proved the primary patency rates from 47% (s.e. 0.12) occlusion. Indeed, stratified for time-of-onset, revision
to 77% (s.e. 0.10) at 30 months’ follow-up (p=0.004) of recurrent stenoses improved the patency rates in
(Fig. 4). The various hazard ratios for reocclusion our study, although this was not investigated in a
obtained with the Cox Proportional Hazard Model are randomised fashion. It remains uncertain whether
listed in Table 3. We also looked at other demographic late asymptomatic restenoses (>1 year) should be
and lesion variables, which are known to be associated left alone (conservative) or treated as well. Currently,
with an increased risk of failure, but these were not we have no data to support any intervention of
found in our study. these lesions.
Other potentially important prognostic factors, such
as run-off score, location of the restenosis, multiplicity
of lesions, maximum PSV ratio, smoking or diabetesDiscussion
were also studied. Wylie and Morton already discussed
the significance and effects of limited outflow afterIn the present study, revision of early recurrent ste-
femoropopliteal endarterectomy back in the 1960s.30,31noses after SFA remote endarterectomy significantly
Although the run-off score tended to be higher in theimproved the primary patency rates at mid-term fol-
low-up. To our knowledge, this has not been published PR group compared to the PNR group, the PR group
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of infrainguinal graft surveillance techniques. J Vasc Surg 1990;still performed better than the PNR group. The location
90: 207–215.of restenoses after SFA remote endarterectomy was 9 Disselhoff B, Buth J, Jakimowitz J. Early detection of stenosis
distributed along the entire endarterectomised seg- of femorodistal bypass grafts. A surveillance study using colour-
duplex scanning. Eur J Vasc Surg 1989; 3: 43–48.ment. Although some authors noted that restenoses
10 Moody P, Gould DA, Harris PL. Vein graft surveillance im-were more frequently found in the distal half of the proves patency in femoropopliteal bypass. Eur J Vasc Surg 1990;
treated vessel and that lesions in the adductor canal 4: 117–127.
11 Barnes RW, Thompson BW, MacDonald CM et al. Serial non-were more likely to progress to occlusion, this could
invasive studies do not herald postoperative failure of femoro-not be reconfirmed in our series.32,33 Apart from “re- popliteal or femorotibial bypass grafts. Ann Surg 1989; 210:
vision” and “time-of-onset”, no other prognostic fac- 486–494.
12 Davies AH, Magee TR, Tennant SGW et al. Criteria for iden-tors for reocclusion could be identified in this study.
tification of the at-risk infrainguinal bypass graft. Eur J Vasc SurgThis may be due to the low number of patients in the 1994; 8: 315–319.
various subgroups. 13 Zwolak RM, Cronenwett JL, McDaniel MD et al. Vascular
laboratory detection of failing lower extremity vein grafts. J VascIn conclusion, recurrrent stenoses were identified
Surg 1991; 13: 910.with colour-flow duplex scanning in 46% after SFA 14 Miller BV, Sharp WJ, Shamma AR et al. Surveillance for re-
remote endarterectomy. Revision and time-of-onset current stenosis after endovascular procedures: a prospective
study. Arch Surg 1991; 126: 867–872.of these restenoses were both prognostic factors for
15 Buth J, Disselhoff B, Sommeling C, Stam L. Colour-flowreocclusion. The results of this study suggest that
duplex criteria for grading stenosis in infrainguinal vein grafts.
revision of early (<1 year) recurrent stenoses improves J Vasc Surg 1991; 14: 716–728.
16 Bandyk DF, Johnson BL, Gupta AK, Esses GE. Nature andthe mid-term patency rates of SFA remote end-
management of duplex abnormalities encountered during infra-arterectomy. Late restenoses developing after 1 year
inguinal vein bypass grafting. J Vasc Surg 1996; 24: 430–438.
do not seem to progress to reocclusion and may be 17 Taylor PR, Wolfe JHN, Tyrrell MR et al. Graft stenosis:
justification for 1-year surveillance. Br J Surg 1990; 77: 1125–1128.treated conservatively.
18 Idu MM, Blankensteijn JD, de Gier P, Truyen E, Buth J.
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1993; 17: 42–53.
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